The risks of indiscriminate use of Femproporex as an appetite inhibitor: a review. RSD [Internet]. 2021 Oct. 16 [cited 2025 Dec. 5];10(13):e35101321246. Available from: https://rsdjournal.org/rsd/article/view/21246